Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Northwest Biotherapeutics ( (NWBO) ) just unveiled an update.
On October 27, 2025, Northwest Biotherapeutics, Inc. entered into a Commercial Loan Agreement with Streeterville Capital, LLC for $5,505,000. The loan has a 22-month maturity with no repayments for the first 8 months, followed by 14 monthly installments starting June 26, 2026. The funds will support ongoing business operations.
More about Northwest Biotherapeutics
Average Trading Volume: 3,437,796
Technical Sentiment Signal: Strong Sell
Current Market Cap: $358M
See more insights into NWBO stock on TipRanks’ Stock Analysis page.